Durvalumab's Benefit in SCLC "Beyond What We Might Have Expected"
MP3•Episode hjem
Manage episode 424098972 series 3560609
Indhold leveret af Jacqueline Stone and Oncololgy News Central. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Jacqueline Stone and Oncololgy News Central eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
From ASCO 2024, Dr. Robert Figlin talks with Dr. Lauren Averett Byers from MD Anderson Cancer Center.
Durvalumab's Benefit in SCLC "Beyond What We Might Have Expected"
130 episoder